| 000 | 01730 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513171625.0 | ||
| 264 | 0 | _c19990712 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0952-3278 | ||
| 024 | 7 |
_a10.1016/s0952-3278(98)90095-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichoud, E | |
| 245 | 0 | 0 |
_aIn vivo effect of 8-epi-PGF2alpha on retinal circulation in diabetic and non-diabetic rats. _h[electronic resource] |
| 260 |
_bProstaglandins, leukotrienes, and essential fatty acids _cDec 1998 |
||
| 300 |
_a349-55 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAngiography |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Flow Velocity |
| 650 | 0 | 4 | _aBridged Bicyclo Compounds, Heterocyclic |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdrug therapy |
| 650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFatty Acids, Unsaturated |
| 650 | 0 | 4 |
_aHydrazines _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhenylacetates _xpharmacology |
| 650 | 0 | 4 | _aProstaglandin H2 |
| 650 | 0 | 4 |
_aProstaglandins H _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRegional Blood Flow |
| 650 | 0 | 4 |
_aRetinal Vessels _xanatomy & histology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aLecomte, M | |
| 700 | 1 | _aLagarde, M | |
| 700 | 1 | _aWiernsperger, N | |
| 773 | 0 |
_tProstaglandins, leukotrienes, and essential fatty acids _gvol. 59 _gno. 6 _gp. 349-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0952-3278(98)90095-3 _zAvailable from publisher's website |
| 999 |
_c10061960 _d10061960 |
||